[Management of severe or corticosteroid resistant ulcerative colitis].
Carbonnel
Franck
F
Service de Gastroentérologie et Nutrition, CHU Jean Minjoz, Besançon, France. fcarbonnel@chu-besancon.fr
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy; D004351:Drug Resistance; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069285:Infliximab; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D011877:Radionuclide Imaging; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D017245:Foscarnet; D016572:Cyclosporine; D000069285:Infliximab; D015774:Ganciclovir